Have a personal or library account? Click to login
Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors Cover

Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors

Radiology and Oncology
Volume 51 (2017): Issue 3 (September 2017)
By: Matjaz Zwitter,  Antonio Rossi,  Massimo Di Maio,  Maja Pohar Perme and  Gilberto Lopes  
Open Access
|Jul 2017

Metrics

DOI: https://doi.org/10.1515/raon-2017-0029 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 241 - 251
Submitted on: May 3, 2017
|
Accepted on: Jun 9, 2017
|
Published on: Jul 18, 2017
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
NSCLC,
intercalated treatment,
EGFR,
tyrosine-kinase inhibitors
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2017 Matjaz Zwitter, Antonio Rossi, Massimo Di Maio, Maja Pohar Perme, Gilberto Lopes, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 51 (2017): Issue 3 (September 2017)Next article